Skip to main navigation Skip to search Skip to main content

Systemic lupus erythematosus-myasthenia gravis overlap syndrome: Presentation and treatment depend on prior thymectomy

  • SUNY Upstate Medical University

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Abstract

In this study, we investigated four patients who met the diagnostic criteria for overlapping systemic lupus erythematosus (SLE) and myasthenia gravis (MG) but responded differently to treatment. All patients were acetylcholine receptor (AChR) and antinuclear antibody positive at the time of SLE diagnosis. Two patients presented with SLE who have been effectively treated with cholinesterase inhibitors for MG. These patients developed SLE with photosensitivity, rash, and arthritis post thymectomy, which had been performed 29 years and 40 years earlier, respectively. Two other patients were found to have AChR antibodies and MG in the context on new-onset SLE. These subjects were responsive to hydroxychloroquine and immunosuppression but failed cholinesterase inhibitors. The evolution of these cases is relevant for the role of thymus in lupus pathogenesis during aging and for treatment selection in SLE-MG overlap patients.

Original languageEnglish
Pages (from-to)100-104
Number of pages5
JournalClinical Immunology
Volume194
DOIs
StatePublished - Sep 2018

Keywords

  • Acetylcholine receptor antibody
  • Antinuclear antibody
  • Antiphospholipid antibody
  • Myasthenia gravis
  • Systemic lupus erythematosus
  • Thymectomy

Fingerprint

Dive into the research topics of 'Systemic lupus erythematosus-myasthenia gravis overlap syndrome: Presentation and treatment depend on prior thymectomy'. Together they form a unique fingerprint.

Cite this